The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Acetaminophen for osteoarthritis
Open accessAbstract
BACKGROUND: Osteoarthritis (OA) is the most common form of arthritis. Published guidelines and expert opinion are divided over the relative role of acetaminophen (also called paracetamol or Tylenol) and non-steroidal anti-inflammatory drugs (NSAIDs) as first-line pharmacologic therapy. The comparative safety of acetaminophen and NSAIDs is also important to consider. This update to the original 2003 review includes nine additional RCTs. OBJECTIVES: To assess the efficacy and safety of acetaminophen versus placebo and versus NSAIDs (ibuprofen, diclofenac, arthrotec, celecoxib, naproxen, rofecoxib) for treating OA. SEARCH STRATEGY: We searched MEDLINE (up to July 2005), EMBASE (2002-July 2005), Cochrane Central Register of Controlled Trials (CENTRAL), ACP Journal Club, DARE, Cochrane Database of Systematic Reviews (all from 1994 to July 2005). Reference lists of identified RCTs and pertinent review articles were also hand searched. SELECTION CRITERIA: Published randomized controlled trials (RCTs) evaluating the efficacy and safety of acetaminophen alone in OA were considered for inclusion. DATA COLLECTION AND ANALYSIS: Pain, physical function and global assessment outcomes were reported. Results for continuous outcome measures were expressed as standardized mean differences (SMD). Dichotomous outcome measures were pooled using relative risk (RR) and the number needed to treat (NNT) was calculated. MAIN RESULTS: Fifteen RCTs involving 5986 participants were included in this review. Seven RCTs compared acetaminophen to placebo and ten RCTs compared acetaminophen to NSAIDs. In the placebo-controlled RCTs, acetaminophen was superior to placebo in five of the seven RCTs and had a similar safety profile. Compared to placebo, a pooled analysis of five trials of overall pain using multiple methods demonstrated a statistically significant reduction in pain (SMD -0.13, 95% CI -0.22 to -0.04), which is of questionable clinical significance. The relative percent improvement from baseline was 5% with an absolute change of 4 points on a 0 to 100 scale. The NNT to achieve an improvement in pain ranged from 4 to 16. In the comparator-controlled RCTs, acetaminophen was less effective overall than NSAIDs in terms of pain reduction, global assessments and in terms of improvements in functional status. No significant difference was found overall between the safety of acetaminophen and NSAIDs, although patients taking traditional NSAIDS were more likely to experience an adverse GI event (RR 1.47, (95% CI 1.08 to 2.00). 19% of patients in the traditional NSAID group versus 13% in the acetaminophen group experienced an adverse GI event. However, the median trial duration was only 6 weeks and it is difficult to assess adverse outcomes in a relatively short time period. AUTHORS' CONCLUSIONS: The evidence to date suggests that NSAIDs are superior to acetaminophen for improving knee and hip pain in people with OA. The size of the treatment effect was modest, and the median trial duration was only six weeks, therefore, additional considerations need to be factored in when making the decision between using acetaminophen or NSAIDs. In OA subjects with moderate-to-severe levels of pain, NSAIDs appear to be more effective than acetaminophen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip
Towheed, T., Mc, H., Shea, B., & Wells, G. A. (1997) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000517 · Cited by 42
Self-citationRetractedStatistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Self-citationSchulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Guccione, A. A., Felson, D. T., Anderson, J. J., Anthony, J. M., Zhang, Y., Wilson, P. W., Kelly-Hayes, M., Wolf, P. A., Kreger, B. E., & Kannel, W. B. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.3.351 · Cited by 1,584
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Gabriel, S. E., Jaakkimainen, L., & Bombardier, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-787 · Cited by 1,237
An update on the epidemiology of knee and hip osteoarthritis with a view to prevention
Felson, D. T., & Zhang, Y. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8<1343::aid-art3>3.0.co;2-9 · Cited by 1,232
Bellamy, N., Kirwan, J., Boers, M., Brooks, P., Strand, V., Tugwell, P., Altman, R. D., Brandt, K. D., Dougados, M., & Lequesne, M. G. (1997) · PubMed · Cited by 745
Glucosamine therapy for treating osteoarthritis
Towheed, T., Maxwell, L., Anastassiades, T. P., Shea, B., Houpt, J., Welch, V., Hochberg, M. C., & Wells, G. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002946.pub2 · Cited by 659
Self-citationMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
Bradley, J. D., Brandt, K. D., Katz, B. P., Kalasinski, L. A., & Ryan, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250203 · Cited by 625
Altman, R., Brandt, K., Hochberg, M., Moskowitz, R., Bellamy, N., Bloch, D. A., Buckwalter, J., Dougados, M., Ehrlich, G., Lequesne, M., et al. (1996) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80101-3 · Cited by 577
Self-citationPendleton, A., Arden, N., Dougados, M., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Cluzeau, F., Cooper, C., Dieppe, P. A., Günther, K.-P., et al. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.12.936 · Cited by 575
Subverting Randomization in Controlled Trials
Schulz, K. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530180050029 · Cited by 516
Osteoarthritis: New Insights. Part 2: Treatment Approaches
Felson, D. T., Lawrence, R. C., Hochberg, M. C., McAlindon, T., Dieppe, P. A., Minor, M. A., Blair, S. N., Berman, B. M., Fries, J. F., Weinberger, M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00015 · Cited by 506
Self-citationZhang, W., Jones, A., & Doherty, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018531 · Cited by 321
A guideline for the treatment and prevention of NSAID-induced ulcers
Lanza, F. L. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00588.x · Cited by 276
Norman, G. R., Gwadry Sridhar, F., Guyatt, G. H., & Walter, S. D. (2001) · Medical Care · doi:10.1097/00005650-200110000-00002 · Cited by 262
James Williams, H., Ward, J. R., Egger, M. J., Neuner, R., Brooks, R. H., Clegg, D. O., Field, E. H., Skosey, J. L., Alarcón, G. S., Willkens, R. F., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360904 · Cited by 262
Clissold, S. P. (1986) · Drugs · doi:10.2165/00003495-198600324-00005 · Cited by 244
A guideline for the treatment and prevention of nsaid-induced ulcers
Lanza, F. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00469-9 · Cited by 239
García Rodríguez, L. A., & Hernández-Díaz, S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar146 · Cited by 236
Geba, G. P., Weaver, A. L., Polis, A. B., Dixon, M. E., Schnitzer, T. J., & for the VACT Group (2002) · JAMA · doi:10.1001/jama.287.1.64 · Cited by 232
Pincus, T., Koch, G. G., Sokka, T., Lefkowith, J., Wolfe, F., Jordan, J. M., Luta, G., Callahan, L. F., Wang, X., Schwartz, T., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1587::aid-art282>3.0.co;2-x · Cited by 229
GARELLA, S., & MATARESE, R. A. (1984) · Medicine · doi:10.1097/00005792-198405000-00003 · Cited by 219
(2003) · Wiley eBooks · doi:10.1002/9781444315844 · Cited by 203
Pincus, T., Koch, G., Lei, H., Mangal, B., Sokka, T., Moskowitz, R., Wolfe, F., Gibofsky, A., Simon, L., Zlotnick, S., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.020313 · Cited by 179
Eccles, M., Freemantle, N., & Mason, J. (1998) · BMJ · doi:10.1136/bmj.317.7157.526 · Cited by 159
Extracts from "Clinical Evidence": Non-steroidal anti-inflammatory drugs
Gøtzsche, P. C. (2000) · BMJ · doi:10.1136/bmj.320.7241.1058 · Cited by 151
Case, J. P., Baliunas, A. J., & Block, J. A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.2.169 · Cited by 147
n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis
MARCH, L. M., Irwig, L., Schwarz, J., et al. (1994) · BMJ · doi:10.1136/bmj.309.6961.1041 · Cited by 142
Arthritis Prevalence and Activity Limitations— United States, 1990
(1994) · JAMA · doi:10.1001/jama.1994.03520050026010 · Cited by 140
Towheed, T., & HOCHBERG, M. (1997) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(97)80043-1 · Cited by 139
Self-citationPincus, T., Swearingen, C. J., Cummins, P., & Callahan, L. F. (2000) · PubMed · Cited by 137
Chronic disease epidemiology and control
(2010) · Choice Reviews Online · doi:10.5860/choice.48-0302 · Cited by 137
Wegman, A. C. M., van der Windt, D., van Tulder, M. W., Stalman, W. A. B., & de Vries, T. P. G. M. (2004) · PubMed · Cited by 132
The Therapeutic Use of Acetaminophen in Patients with Liver Disease
Benson, G. D., Koff, R. S., & Tolman, K. G. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000140216.40700.95 · Cited by 131
Lee, C., Straus, W. L., Balshaw, R. F., Barlas, S., Vogel, S., & Schnitzer, T. J. (2004) · Arthritis Care & Research · doi:10.1002/art.20698 · Cited by 127
Costs and outcomes in rheumatoid arthritis and osteoarthritis
Liang, M. H., Larson, M. G., Thompson, M., Eaton, H. M., McNamara, E. A., Katz, R. S., & Taylor, J. E. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270507 · Cited by 126
Bradley, J. D., Brandt, K. D., Katz, B. P., Kalasinski, L. A., & Si, R. (1992) · PubMed · Cited by 109
Pharmacological therapy of osteoarthritis
Hochberg, M. C., & Dougados, M. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0175 · Cited by 104
Self-citationBoureau, F., Schneid, H., Zeghari, N., Wall, R., & Bourgeois, P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011403 · Cited by 91
Paracetamol in osteoarthritis of the knee
Miceli‐Richard, C., Bars, M. L., Schmidely, N., & Dougados, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017236 · Cited by 83
The Role of Paracetamol in Chronic Pain: An Evidence-Based Approach
Nikles, J., Yelland, M. J., Mar, C. D., & Wilkinson, D. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00011 · Cited by 82
Key questions concerning paracetamol and NSAIDs for osteoarthritis
Courtney, P., & Doherty, M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.9.767 · Cited by 63
Fries, J. F., & Bruce, B. (2003) · PubMed · Cited by 55
Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip
Towheed, T., Hochberg, M. C., Shea, B., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000517.pub2 · Cited by 52
Self-citationActions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.
Swierkosz, T. A., Jordan, L., McBride, M. L., McGough, K., Devlin, J., & Botting, R. M. (2002) · PubMed · Cited by 47
Schnitzer, T. J., Weaver, A. L., Polis, A. B., Petruschke, R. A., & Geba, G. P. (2005) · PubMed · Cited by 41
A consumer's guide to finding, evaluating, and reporting on measurement instruments
DeVellis, R. F. (1996) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199606)9:3<170::aid-anr1790090304>3.0.co;2-k · Cited by 38
Bradley, J. D., Katz, B. P., & Brandt, K. D. (2001) · PubMed · Cited by 38
Published meta-analyses of pharmacological therapies for osteoarthritis
Towheed, T. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0841 · Cited by 37
Self-citationGolden, H. E., Moskowitz, R. W., & Minić, M. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200403000-00002 · Cited by 34
Analgesics and Osteoarthritis: Are Treatment Guidelines Reflected in Clinical Practice?
Jawad, A. S. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00013 · Cited by 34
Shamoon, M., & Hochberg, M. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0020-z · Cited by 31
Self-citationThe role of acetaminophen in the management of patients with osteoarthritis
Shamoon, M., & Hochberg, M. C. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00618-0 · Cited by 28
Self-citationGravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Lawrence (1998) · doi:10.1002/1529-0131(199805)41:5<778::aid-art4>3.0.co;2-v
Cited by
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Self-citationChou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
OARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Self-citationZhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Abramoff, B., & Caldera, F. E. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.10.007 · Cited by 1,191
Metadata
- Authors
- Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-01-25
- Volume
- 2010
- Issue
- 1
- Pages
- CD004257-CD004257
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2118200369
- Cited by
- 563
- References
- 66
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.